Edition:
United Kingdom

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

2.58USD
12 Dec 2017
Change (% chg)

$-0.03 (-1.15%)
Prev Close
$2.61
Open
$2.56
Day's High
$2.70
Day's Low
$2.55
Volume
33,028
Avg. Vol
27,443
52-wk High
$5.74
52-wk Low
$2.02

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Steven Elms

53 Chairman of the Board

Adam Grossman

38 2011 President, Chief Executive Officer, Director

Jerrold Grossman

67 Vice Chairman of the Board

Brian Lenz

43 2012 Chief Financial Officer

James Mond

69 2012 Chief Scientific and Medical Officer